Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

NCT04058470 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Follicular Lymphoma Grade IIIb
Transformed Lymphoma
EBV-Positive DLBCL, Nos
ALK-Positive Anaplastic Large Cell Lymphoma

Interventions

DRUG: Toripalimab, Rituximab
DRUG: R-CHOP Protocol

Sponsor

Huiqiang Huang